Search

everythinglearnresearchcommunity

for

Search:↓

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Treatment during development affects hormone balance and sexual behavior in male rats.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Using stem cells from fat tissue can significantly improve wound healing in dogs.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

In vivo lineage labelling is better than in vitro methods for identifying and understanding stem cells.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Created microspheres show potential for safe and effective use in prostate artery embolization.

Granulation tissue-derived cells can aid wound healing and serve as an alternative source of stem cells for tissue repair.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

AGA affects many, progresses differently, and early treatment is crucial.

Dutasteride reduces DHT more effectively than finasteride.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Androgen and Wnt signals are crucial for developing and functioning male genitalia and erectile tissues.

Current therapies cannot fully regenerate adult skin without scars; more research is needed for scar-free healing.

Organoids can revolutionize medicine by modeling diseases and aiding in personalized treatments.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Finasteride may help prevent prostate cancer.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.